Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”

Affiliations

Paul Y. Kwo: Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA

Abstract

No abstracts available.

ISSN: 2287-2728 (Print); 2287-285X (Online)
Publisher: Korean Association for the Study of the Liver
Country of publisher: Korea, Republic of
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: http://www.e-cmh.org